Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
PLoS One ; 12(6): e0180022, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28662177

RESUMO

The toxicity of in vitro tested compounds is usually evaluated based on AC50 values calculated from dose-response curves. However, there is a large group of compounds for which a standard four-parametric sigmoid curve fitting may be inappropriate for estimating AC50. In the present study, 22 polyphenol-rich compounds were prioritized from the least to the most toxic based on the total area under and over the dose-response curves (AUOC) in relation to baselines. The studied compounds were ranked across three key cell indicators (mitochondrial membrane potential, cell membrane integrity and nuclear size) in a panel of five cell lines (HepG2, Caco-2, A549, HMEC-1, and 3T3), using a high-content screening (HCS) assay. Regarding AUOC score values, naringin (negative control) was the least toxic phenolic compound. Aronox, spent hop extract and kale leaf extract had very low cytotoxicity with regard to mitochondrial membrane potential and cell membrane integrity, as well as nuclear morphology (nuclear area). Kaempferol (positive control) exerted strong cytotoxic effects on the mitochondrial and nuclear compartments. Extracts from buckthorn bark, walnut husk and hollyhock flower were highly cytotoxic with regard to the mitochondrion and cell membrane, but not the nucleus. We propose an alternative algorithm for the screening of a large number of agents and for identifying those with adverse cellular effects at an early stage of drug discovery, using high content screening analysis. This approach should be recommended for series of compounds producing a non-sigmoidal cell response, and for agents with unknown toxicity or mechanisms of action.


Assuntos
Ensaios de Triagem em Larga Escala/métodos , Extratos Vegetais/toxicidade , Polifenóis/toxicidade , Animais , Linhagem Celular , Humanos , Camundongos
2.
Arch Physiol Biochem ; 123(1): 54-60, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27855519

RESUMO

Hop cones (Humulus lupulus L.), very rich source of phenolic compounds, possessing anticancer, antioxidant and anti-inflammatory activities, are considered as beneficial diet ingredients improving human health. In this study, the antiplatelet action of xanthohumol (XN), the principal flavonoid in hop cones, was investigated. XN significantly attenuated ADP-induced blood platelet aggregation (97.2 ± 35.7 AU for 6 µg/ml of XN vs. 120.4 ± 30.1 AU for 0.17% dimethyl sulfoxide (DMSO), p < 0.001) and significantly reduced the expression of fibrinogen receptor (activated form of GPIIbIIIa) on platelets' surface (47.6 ± 15.8 for 1.5 µg/ml XN, 44.6 ± 17.3% for 3 µg/ml XN vs. 54.5 ± 19.2% for control or 43.3 ± 18.4% for 6 µg/ml XN vs. 49.7 ± 19.4% for 0.17% DMSO, p < 0.05 or less). These findings suggest that the phenolic compounds originating from hops (XN) have a novel role as antiplatelet agents and can likely be used as dietary supplements in prophylactic approaches.


Assuntos
Suplementos Nutricionais , Flavonoides/metabolismo , Humulus/química , Resíduos Industriais/análise , Inflorescência/química , Ativação Plaquetária , Inibidores da Agregação Plaquetária/metabolismo , Propiofenonas/metabolismo , Adulto , Animais , Biomarcadores/sangue , Biomarcadores/metabolismo , Suplementos Nutricionais/análise , Suplementos Nutricionais/economia , Feminino , Flavonoides/economia , Flavonoides/isolamento & purificação , Indústria de Processamento de Alimentos/economia , Humanos , Resíduos Industriais/economia , Masculino , Camundongos Endogâmicos C57BL , Selectina-P/sangue , Selectina-P/metabolismo , Extratos Vegetais/química , Extratos Vegetais/economia , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/metabolismo , Agregação Plaquetária , Inibidores da Agregação Plaquetária/economia , Inibidores da Agregação Plaquetária/isolamento & purificação , Complexo Glicoproteico GPIIb-IIIa de Plaquetas/antagonistas & inibidores , Complexo Glicoproteico GPIIb-IIIa de Plaquetas/metabolismo , Propiofenonas/economia , Propiofenonas/isolamento & purificação , Propriedades de Superfície , Tromboxano B2/sangue , Tromboxano B2/metabolismo , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA